News | News By Subject | News by Disease News By Date | Search News

Hormonal Disorder (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Amgen (AMGN) Remains Hush-Hush Over FDA Rejection of Parsabiv     8/25/2016
Lipocine (LPCN) Shares Slump as FDA Does Not Approve NDA for Testosterone Drug LPCN 1021     6/29/2016
Chiasma Crashes on FDA Drug Rejection of Mycapssa     4/18/2016
Repros Therapeutics (RPRX) Stock Plunges as FDA Advisory Panel Cancels Enclomiphene Review     10/30/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Shire (SHPGY)'s $5.2 Billion Bet Pays Off as NPS Pharmaceuticals, Inc. (NPSP)'s Natpara Wins Approval     1/27/2015
Opko Health, Inc. (OPK) Rockets After Striking Deal Worth $570 Million With Pfizer (PFE)     12/17/2014
FDA Approves Novartis AG (NVS) Drug For Rare Hormonal Disorder     12/17/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Postpones Its Final Decision On NPS Pharmaceuticals, Inc. (NPSP)'s Natpara     10/24/2014
Pfizer Inc. (PFE) Pursues Early Approval For Breast Cancer Drug     5/19/2014
FDA Rejects Endo Health Solutions Inc. (Formerly Known as Endo Pharmaceuticals Holdings Inc.) (ENDP) Testosterone Drug, Again     6/3/2013
Novartis AG (NVS) Drug Signifor® Gains FDA Approval for Cushing's Disease     12/17/2012
Novartis AG (NVS): Pasireotide Works Well in Phase III Acromegaly Trial     5/9/2012

News from Around the Web
Higher Thyroid Hormone Levels Linked To Sudden Cardiac Death, AHA Reveals     9/7/2016
Family Stunts Disabled Daughter's Growth To Expand Her World     10/26/2015
Hormone Linked to Death Risk in Those With Early Kidney Disease, University of Miami Study     6/15/2011
Experts Say Hormone Replacement Generally Safe in Short-Term, Columbia University Study     6/10/2011
Older Age Does Not Cause Testosterone Levels to Decline in Healthy Men, University of Sydney Study     6/8/2011
Estrogen's Role in Breast Cancer Can Fluctuate, Georgetown University Study Finds     4/15/2011
Serotonin Sex Bomb: How to Make a Mouse Bisexual or Just Really Aroused, National Institute of Biological Sciences Reveals     3/28/2011
Hormones May be Better Than Soy for Hot Flashes, Robert Wood Johnson University Hospital     3/16/2011
Hormone Injection Diet Raises FDA Cautions     3/10/2011
Hormone Spike in Women with Post Traumatic Stress Disorder, Emory University Study     3/2/2011
Don't Blame the Pill for Estrogen in Drinking Water, Study Published in Environmental Science & Technology     2/15/2011
Estrogen Linked with Lower Dementia Risk When Taken in Middle Age, Higher Risk Later in Life, San Francisco Veterans Affairs Medical Center and University of California, San Francisco (UCSF) Study     2/2/2011
Oxytocin Can Bring Back 'Unloving' Memories in Men, Too - Mount Sinai School of Medicine Study     11/30/2010
Why Estrogen Makes You Smarter, Northwestern University Study     11/18/2010
Low Testosterone Levels Linked to Early Heart Death, Royal Hallamshire Hospital Study Says     10/20/2010

Press Releases
Dermira (DERM) To Present Data From DRM04 Phase III Clinical Trials At Late-Breaking News Session At European Academy Of Dermatology And Venereology Congress     9/28/2016
Repros Therapeutics (RPRX) Release: FDA Schedules Advisory Committee Meeting To Discuss Secondary Hypogonadism     9/26/2016
Antares Pharma (ATRS) Announces Completion Of The Quickshot Testosterone Clinical Program     9/22/2016
Dermira (DERM) Licenses DRM04 To Maruho For Hyperhidrosis In Japan     9/21/2016
Viking Therapeutics (VKTX) Presents Phase 1 Data And Highlights Ongoing Phase 2 Study Of VK5211 At 5th Fragility Fracture Network Global Congress 2016     9/1/2016
Ascendis Pharma A/S To Present At The UBS Global Healthcare Conference On May 23, 2016     5/18/2016
Mission Pharmacal Company Receives FDA Approval For Liquid Potassium Iodide Oral Solution For Nuclear Emergency Management     5/17/2016
Brickell Biotech Release: BBI-4000 (Sofpironium Bromide) Demonstrates Promising Potential As A Safe And Effective First-Line Treatment For Excessive Underarm Sweating     3/7/2016
Deltanoid Pharmaceuticals, Inc. Announces Appointment Of Douglas Jermasek As Chief Executive Officer     2/2/2016
AGTC (AGTC) Announces Data Evaluating Novel AAV-Based Gene Therapy As A Potential Treatment For Alpha-1 Antitrypsin (AAT) Deficiency     1/20/2016
Debiopharm International SA And Arbor Pharmaceuticals Announce Their US Commercialization Partnership For Triptorelin In Central Precocious Puberty     1/11/2016
Revance Therapeutics, Inc. (RVNC) Specifies 2016 Clinical Program Milestones     1/8/2016
Brickell Biotech Achieves Statistically Significant And Clinically Meaningful Phase IIb Results For BBI-4000 (Sofpironium Bromide) In Patients With Hyperhidrosis     12/17/2015
Viking Therapeutics (VKTX) Presents New Data On VK5211 Demonstrating Robust Weight Gain In Primates Following 13 Weeks Of Treatment     12/7/2015
Strongbridge Biopharma Announces Issuance Of U.S. Patent For Investigational COR-003 (Levoketoconazole) In Treatment Of Endogenous Cushing's Syndrome     12/7/2015